Canton Strategic Holdings (CNTN) Amortizatization of Intangibles (2021 - 2022)
Canton Strategic Holdings (CNTN) reported Amortizatization of Intangibles of $1.6 million for Q1 2022, up 1275.18% on a YoY basis from $114094.0 in Q1 2021, and up 641.62% quarter-over-quarter from $211563.0 in Q4 2021.
Canton Strategic Holdings (CNTN) Amortizatization of Intangibles (2021 - 2022) Analysis & Trends
Canton Strategic Holdings has reported Amortizatization of Intangibles for 2 years, with the latest figure at $1.6 million in Q1 2022.
- For the quarter ending Q1 2022, Amortizatization of Intangibles rose 1275.18% year-over-year to $1.6 million; the trailing twelve-month figure through Dec 2022 stood at $1.6 million (up 135.39% YoY), and the FY2022 full-year result was $1.6 million, up 135.39% from the prior year.
- Amortizatization of Intangibles for Q1 2022 stood at $1.6 million, up from $211563.0 in the prior quarter.
- The five-year high for Amortizatization of Intangibles was $1.6 million in Q1 2022, with the low at $114094.0 in Q1 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Canton Strategic Holdings | 699.97 Mn | 658.44 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 1.57 Mn |
| Mar 31, 2022 | 1.57 Mn |
| Dec 31, 2021 | 211,563.00 |
| Dec 31, 2021 | 211,563.00 |
| Sep 30, 2021 | 191,040.00 |
| Sep 30, 2021 | 191,040.00 |
| Jun 30, 2021 | 149,869.00 |
| Jun 30, 2021 | 149,869.00 |
| Mar 31, 2021 | 114,094.00 |
| Mar 31, 2021 | 114,094.00 |